Investment Team

Active Responsibilities
Select Prior Responsibilities

P. Sherrill Neff

  • Founding Partner of Quaker Partners
  • Previously: President, COO, and Director, Neose Technologies, a life sciences company. Senior VP, Corporate Development, U.S. Healthcare, a publicly traded managed care company. Managing Director, Investment Banking Division, Alex. Brown & Sons. Corporate Attorney at Morgan, Lewis & Bockius.
  • Active Responsibilities: Intact Vascular, Neuronetics, and Vesper Medical
  • Select Prior Responsibilities: Achillion Pharmaceuticals (Nasdaq: ACHN), Amicus Therapeutics (Nasdaq: FOLD), BioRexis (acquired by Pfizer), Cempra Pharmaceuticals, Durata Therapeutics (acquired by Actavis), Medmark (acquired by Walgreen Co.), Protez Pharmaceuticals (acquired by Novartis), RainDance Technologies (acquired by Bio-Rad) and Tobira Therapeutics (acquired by Allergen) (formerly Regado Biosciences)
  • Other: Board of Directors, Exantas Capital Corp. (NYSE:XAN); KBL Merger Corp. (Nasdaq:KBLM); Former Chairman, Policy Board; WXPN-FM, listener supported radio from the University of Pennsylvania; Board of Directors, Jack M. Barrack Hebrew Academy; Former Director, National Venture Capital Association (NVCA); Former Chairman, Greater Philadelphia Venture Group; Former President, Pennsylvania Biotechnology Association; Former board member, University City Science Center, Biotechnology Institute and Vesper Boat Club
  • Education: B.A. from Wesleyan University and J.D. magna cum laude from the University of Michigan Law School